Medical supply firm Medline jumps more than 25% in debut after biggest IPO of 2025
Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.
TL;DR
- Medline's shares jumped over 22% on its Nasdaq debut, trading under the symbol MDLN.
- The IPO raised $6.26 billion, making it the largest initial public offering globally for the year.
- Medline, a medical supplies manufacturer and distributor, has customers in over 100 countries.
- The company was acquired by private equity firms Blackstone, Carlyle, and Hellman & Friedman in 2021 for $34 billion.
- Medline's total debt was approximately $16.8 billion as of late September 2025, with net sales of $25.5 billion in 2024.
- Previous IPO plans were postponed due to tariff uncertainties, with expected fiscal 2026 impacts of $150 million to $200 million.